Alle patienter i undersøgelsen var først blevet stabiliseret med andre behandlinger for skizofreni og havde taget olanzapin i tabletform i mindst seks uger, inden undersøgelsen startede.
All of the patients in this study had been stabilised with other treatments for schizophrenia and had been taking olanzapine by mouth for at least six weeks before the study began.